WANDERCRAFT
Clinical Trials
11
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
- Conditions
- Spinal Cord InjuryTetraplegia/TetraparesisParaplegia, CompleteParaplegia, IncompleteGuillain Barré Syndrome
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Wandercraft
- Target Recruit Count
- 35
- Registration Number
- NCT06939634
- Locations
- 🇫🇷
Fondation Hopale, Berck, France
🇫🇷CMPR de Pionsat, Pionsat, France
🇫🇷Hôpital La Musse, Saint Sébastien de Morsent, France
Self-balancing Personal Exoskeleton for SCI (site 2)
- Conditions
- Spinal Cord Injuries (SCI)Paraplegia and Tetraplegia
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Wandercraft
- Target Recruit Count
- 10
- Registration Number
- NCT06814015
- Locations
- 🇺🇸
Kessler Foundation, West Orange, New Jersey, United States
Self-balancing Personal Exoskeleton for SCI
- Conditions
- Spinal Cord Injuries (SCI)Paraplegia and Tetraplegia
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Wandercraft
- Target Recruit Count
- 24
- Registration Number
- NCT06777576
- Locations
- 🇺🇸
James J. Peters, VA Medical Center, Bronx, NY, Bronx, New York, United States
Human Factors Validation Testing of the Wandercraft Personal Exoskeleton
- Conditions
- Spinal Cord InjuriesTetraplegiaParaplegia
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Wandercraft
- Target Recruit Count
- 14
- Registration Number
- NCT06715631
- Locations
- 🇫🇷
Wandercraft, Paris, France
Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population
- Conditions
- Spinal Cord InjuriesNeurodegenerative DiseasesCerebrovascular AccidentMotor DisordersGait Disorders, NeurologicWeakness, Muscle
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Wandercraft
- Target Recruit Count
- 100
- Registration Number
- NCT06538974
- Locations
- 🇫🇷
Wandercraft, Paris, France
- Prev
- 1
- 2
- 3
- Next
News
Wandercraft Initiates Landmark Trial for Hands-Free Personal Exoskeleton in SCI Patients
Wandercraft has launched a groundbreaking clinical trial for its Personal Exoskeleton technology, designed to provide hands-free walking independence for individuals with severe mobility impairments.
European AI Healthcare Startups Drive Medical Innovation with Advanced Analytics and Clinical Trial Solutions
• The European healthcare sector is experiencing rapid growth in AI-focused startups, with approximately 7,754 healthcare companies incorporating AI technology across the continent. • Leading AI biotech firms like Owkin and Qureight are partnering with major pharmaceutical companies to accelerate drug development and improve clinical trial efficiency through advanced data analytics. • AI applications in healthcare span from exoskeleton development for paralyzed patients to reproductive medicine and clinical data analysis, with companies focusing on patient care improvement and drug discovery optimization.